Chromatin Bioscience
Edinburgh
About Chromatin Bioscience
Chromatin Bioscience develops synthetic promoter systems by identifying and engineering natural gene regulatory elements using a bioinformatics platform. Its services include designing cell-type-selective promoters for gene and cell therapy, enhancing protein yields in biologics production, and creating tailored promoters for industrial and agricultural biotechnology. The platform integrates algorithmic analysis of genomic data to generate optimized gene expression cassettes for diverse applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Grant (Jan 2026)
- Website: chromatinbio.com
Social Profiles
Canonical: https://fsome.com/organization/chromatin-bioscience-47723 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.